00927nas a2200361   4500000000100000008004100001260001200042653002300054653001200077653002100089653004700110653002600157653002100183653001900204653002000223653002000243653002200263653001500285653002800300653002800328100001400356700001600370700001500386700001200401700001100413700001200424700001100436700001700447700001400464700001700478245005600495022001400551       2020                            d  c03/202010aHansen’s disease10aleprosy10aLucio phenomenon10aNational Hansen’s Disease Program (NHDP)10aand immunoprophylaxis10achemoprophylaxis10adisease burden10adisease relapse10adrug resistance10aleprosy treatment10aprevention10atype 1 leprosy reaction10aType 2 leprosy reaction1 aMaymone M1 aVenkatesh S1 aLaughter M1 aAbdat R1 aHugh J1 aDacso M1 aRao NP1 aStryjewska B1 aDunnick C1 aDellavalle R00aLeprosy: Treatment and Management of Complications.  a1097-6787